期刊文献+

促纤维增生/结节型髓母细胞瘤病理学特点及相关信号通路研究 被引量:4

Analysis of pathological characteristic in desmoplastic/nodular medulloblastoma
原文传递
导出
摘要 目的探讨促纤维增生/结节型髓母细胞瘤(DNMB)的组织病理学特征和瘤细胞分化相关的信号通路。方法采用HE染色、Reticulin染色和免疫组织化学染色等方法,对803例髓母细胞瘤石蜡样本进行分析。结果103例样本(103/803)确诊为DNMB,HE染色显示DNMB存在无网状纤维的结节样苍白岛,并由致密的多形性细胞及网状纤维围绕。所有样本Reticulin染色后,可见结节间存在银染成黑色的网状纤维。免疫组化结果:结节内细胞呈现胞质NSE、Syn阳性表达,胞核Neu-N阳性表达;结节内Ki-67标记指数与结节间相比明显较低;GABl和filaminA抗体染色显示结节间及周围细胞胞质阳性,结节内细胞部分表达;B-catenin抗体染色显示结节内、外细胞胞质阳性,但胞核均为阴性。结论DNMB是髓母细胞瘤中组织学形态较为特殊的亚型,Reticulin染色是重要的诊断方法,该肿瘤细胞分化与SHh信号通路激活存在密切联系。 Objective To analysis clinic pathological characteristic of desmoplastic/nodular medulloblastoma (DNMB). Methods HE staining, Reticulin staining and immunohistochemisty staining were performed in 803 formalin fixed paraffin embedded tissues of medulloblastomas, to analysis the characteristic of DNMB. Results 103 cases ( 103/803 ) were identified DNMB with typical nodular, reticulin -free zones surrounded by densely intercellular reticulin fiber network. Intranodular cells were positive for NSE, Syn and Neu - N were found in DNMB, and Ki - 67 labeling indices were lower than Internodular regions. Retieulin staining showed positive for reticulin fibers in Internodular regions. Intemodular regions of this DNMB showed strong cytoplasmic staining for GAB1 and filamin A, but negligible reactivity within nodules. Both Intemodular and Intranodular regions showed cytoplasmic staining for[5- catenin. Conclusions DNMB is the distinct subtype of medulloblastoma with characteristic histological appearance, Mechanism of tumorigeness of DNMB is correlates of Sonic Hedgehog pathway.
出处 《中华神经外科杂志》 CSCD 北大核心 2012年第10期1040-1044,共5页 Chinese Journal of Neurosurgery
基金 国家科技支撑计划(2012BAIl2803) 北京市自然科学基金(7112049)
关键词 髓母细胞瘤 促纤维增生/结节型 病理学 Medulloblastoma Desmoplastic/nodular Pathology
  • 相关文献

参考文献3

二级参考文献24

  • 1Chan AW, Tarbell NJ, Black PM, et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery, 2000, 47:623-632.
  • 2Whelan HT, Krouwer HG, Schmidt MH, et al. Current therapy and new perspectives in the treatment of medulloblastoma. Pediatr Neurol, 1998,18 : 103-115.
  • 3Garton GR, Schomberg P J, Scheithauer BW, et al. Medulloblastoma-prognostic factors and outcome of treatment: Review of the Mayo Clinic experience. Mayo Clin Proc, 1990,65 : 1077-1086.
  • 4Roberts RO, Lynch CF, Jones MP, et al. Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol, 1991,50:134-144.
  • 5Pramanik P, Sharma MC, Mukhopadhyay P, et al. A comparative study of classical vs. desmoplastic medulloblastomas. Neurol India, 2003, 51:27-34.
  • 6Leonard JR, Cai DX, Rivet D J, et al. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. J Neurosurg, 2001,95:82-88.
  • 7Hubbard JL, Scheithauer BW, Kispert DB, et al. Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum. J Neurosurg, 1989,70:536-544.
  • 8Packer RJ, Sutton LN, Rorke LB, et al. Prognostic importance of cellular differentiation in medulloblastoma of childhood. J Neurosurg, 1984,61:296-301.
  • 9Burger PC, Bliestle GA, Kleihues P. Differentiation in the medulloblastoma. Acta Neuropathol, 1987,73 : 115-123.
  • 10Carrie C, Lasset C, Alapetite C, et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Cancer, 1994,74:2352-2360.

共引文献35

同被引文献36

  • 1殷晓璐,彭颂先,吴浩强.髓母细胞瘤全基因组的等位基因型分析[J].中华病理学杂志,2004,33(5):413-415. 被引量:4
  • 2Louis DN,Ohgaki H,Wiestler OD,et al.WHO classification of tumours of the central nervous system[M].Lyon:IARC Press,2007:132-140.
  • 3Silvani A,Gaviani P,Lamperti E,et al.Adult medulloblastoma:multiagent chemotherapy with cisplatinum and etoposide:a singleinstitutional experience[J].J Neurooncol,2012,106 (3):595-600.
  • 4Eberhart CG,Kepner JL,Goldthwaite PT,et al.Histopathologic grading of medulloblastomas:a Pediatric Oncology Group study[J].Cancer,2002,94(2):552-560.
  • 5Northcott PA,Shih DJ,Peacock J,et al.Subgroup-specific structural variation across 1,000 medulloblastoma genomes[J].Nature,2012,488 (7409):49-56.
  • 6Northcott PA,Shih D J,Remke M,et al.Rapid,reliable,and reproducible molecular sub-grouping of clinical medulloblastoma samples[J].Acta Neuropathol,2012,123(4):615-626.
  • 7von Hoff K,Hartmann W,von Bueren AO,et al.Large cell/ anaplastic medulloblastoma:outcome according to myc status,histopathological,and clinical risk factors[J].Pediatr Blood Cancer,2010,54(3):369-376.
  • 8Rodriguez FJ,Eberhart C,O' Neill BP,et al.Histopathologic grading of adult medulloblastomas[J].Cancer,2007,109 (12):2557-2565.
  • 9Lai R.Survival of patients with adult medulloblastoma:a population-based study[J].Cancer,2008,112(7):1568-1574.
  • 10Min HS,Lee YJ,Park K,et al.Medulloblastoma:histopathologic and molecular markers of anaplasia and biologic behavior[J].Acta Neuropathol,2006,112 (1):13-20.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部